Erik Magnus Ohman

TL;DR: Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means.

TL;DR: The usefulness of base-line levels of cardiac troponin T and CK-MB and the electrocardiographic category assigned at admission and the presence of confounding factors that impair the detection of ischemia were assessed to assess the usefulness of outcome.

TL;DR: Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrine therapy and platelet glycoprotein IIb/IIIa inhibition : the GUSTO V randomised trial.

TL;DR: This information is current as of October 25, 2011 and can be found at: http://content.onlinejacc.org/cgi/content/full/57/11/1330 located on the World Wide Web at:

TL;DR: Reocclusion of the infarct-related artery after successful reperfusion is associated with substantial morbidity and mortality rates and new strategies in the postinfarction period need to be developed to prevent reocclusion.